https://www.indianpharmapost.com/astec-lifesciences-posts-q4fy24-consolidated-loss-at-rs-9739-lakhs-155982024-05-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/dabur-india-posts-q4-fy24-consolidated-pat-at-rs-34953-cr-155992024-05-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/wipro-to-implement-independent-healths-medicare-prescription-payment-plan-platform-156002024-05-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/ajanta-pharma-posts-q4-fy24-consolidated-pat-at-rs-20272-cr-156012024-05-04T00:00:00+05:30always0.9